![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, January 31, 2020 7:14:03 AM
The "BioElectronics Corp (BIEL) - Product Pipeline Analysis, Update" company profile has been added to ResearchAndMarkets.com's offering.
Summary
BioElectronics Corp (BioElectronics) is a provider of non-invasive electroceuticals devices. It develops, manufactures and markets disposable, drug-free and non-invasive pain therapy devices for treating chronic pains and inflammation. The company' product portfolio include ActiPatch for the treatment for musculoskeletal pain relief; Allay, a menstrual pain therapy; Smart Insole for the treatment of heel pain; HealFast, a device developed for treating pain in dogs, cats and horses, and RecoveryRx, for relief from pain from postoperative recovery and chronic wounds. The company uses its pulsed shortwave electromagnetic field therapy technology for the development of its products. It offers products to hospitals and clinics through a network of wholesale distributors throughout the world. BioElectronics is headquartered in Frederick, Maryland, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company BioElectronics Corp
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Key Topics Covered:
BioElectronics Corp Company Overview
BioElectronics Corp Company Snapshot
BioElectronics Corp Pipeline Products and Ongoing Clinical Trials Overview
BioElectronics Corp - Pipeline Analysis Overview
Business Description
BioElectronics Corp - Key Facts
BioElectronics Corp - Major Products and Services
BioElectronics Corp Pipeline Products by Development Stage
BioElectronics Corp Ongoing Clinical Trials by Trial Status
BioElectronics Corp Pipeline Products Overview
Actipatch - Expanded Indications
Actipatch - Expanded Indications Product Overview
Actipatch - Expanded Indications Clinical Trial
Allay Menstrual Pain Relief Patch
Allay Menstrual Pain Relief Patch Product Overview
Allay Menstrual Pain Relief Patch Clinical Trial
RecoveryRx - Breast Augmentation(OTC)
RecoveryRx - Breast Augmentation(OTC) Product Overview
RecoveryRx - Post Operative Edema (OTC)
RecoveryRx - Post Operative Edema (OTC) Product Overview
BioElectronics Corp - Key Competitors
BioElectronics Corp - Key Employees
BioElectronics Corp - Locations And Subsidiaries
1/30/2020 6:26:36 PM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM